Drugs.com - New Drug Approvals

FDA Approves Harliku (nitisinone) for the Treatment of Patients with Alkaptonuria

BOSTON, Massachusetts and Cambridge, UK – June 19, 2025 – Cycle Pharmaceuticals announced that the FDA has approved Harliku (nitisinone) Tablets for the reduction of urine homogentisic acid (HGA) in adult patients with AKU.1 Launching...

Jun 24, 2025 - 03:05
 0
FDA Approves Harliku (nitisinone) for the Treatment of Patients with Alkaptonuria
BOSTON, Massachusetts and Cambridge, UK – June 19, 2025 – Cycle Pharmaceuticals announced that the FDA has approved Harliku (nitisinone) Tablets for the reduction of urine homogentisic acid (HGA) in adult patients with AKU.1 Launching...
Read More

Tags:

Previous Article

Perfumes: the top 5 key points of the 2025 SIMPPAR show in Paris

Next Article

Kia EV3 Winning World Car of the Year is Old News but Good News

Related Posts

Datroway Approved in the U.S. as First TROP2 Directed Therapy for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Datroway Approved in the U.S. as First TROP2 Directed T...

Jun 24, 2025  0

FDA Approves Penpulimab-kcqx for the Treatment of Advanced Nasopharyngeal Carcinoma

FDA Approves Penpulimab-kcqx for the Treatment of Advan...

May 12, 2025  0

U.S. FDA Approves Tablet Formulation of BeOne’s Brukinsa for All Approved Indications

U.S. FDA Approves Tablet Formulation of BeOne’s Brukins...

Jun 12, 2025  0